Skip to main content
Stacy Croteau, MD, Hematology, Boston, MA, Boston Children's Hospital

StacyE.CroteauMD

Hematology Boston, MA

Hemophilia & Bleeding Disorder

Director Hemophilia/VWD Program, Boston Children's Hospital Assistant Professor of Pediatrics, Harvard Medical School

Dr. Croteau is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Croteau's full profile

Already have an account?

Education & Training

  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2011 - 2014
  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterResidency, Pediatrics, 2007 - 2011
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 2007

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2010 - 2025
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Advances in Hemophilia A: Expert Guidance and Practical Case Discussions 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Risk Factors for Hospital-Acquired Venous Thromboembolism in Children: Findings from the Children’s Hospital-Acquired Thrombosis (CHAT) Registry 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Thrombotic Events with NovoSeven® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Gene Therapy Can Transform Life for People with Hemophilia. But Some Patients Don’t Want It
    Gene Therapy Can Transform Life for People with Hemophilia. But Some Patients Don’t Want ItJanuary 29th, 2023
  • BioMarin: Depressed Price Due to CRL, Major Catalysts Ahead
    BioMarin: Depressed Price Due to CRL, Major Catalysts AheadJune 1st, 2021
  • Gene Therapy for Hemophilia: Progress and Setbacks
    Gene Therapy for Hemophilia: Progress and SetbacksOctober 20th, 2020
  • Join now to see all

Hospital Affiliations